Hologic Inc (HOLX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Hologic Inc (HOLX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011735
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through a network of direct sales and service forces and through independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Hologic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Hologic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Hologic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Hologic Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Hologic Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 12
Private Equity 13
Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 13
Partnerships 14
MeVis Medical Enters into Licensing Agreement with Hologic 14
Microsulis Medical Enters Into Licensing Agreement With Hologic 15
Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 16
Seegene Enters into Agreement with Hologic 17
U.S. Department of Health and Human Services Enters into Agreement with Hologic 18
Bovie Medical Enters into Agreement with Hologic 19
Metamark Genetics Enters into Distribution Agreement with Hologic 20
Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 21
Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 22
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 23
Debt Offering 24
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 24
Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 25
Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 26
Asset Transactions 27
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 27
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 29
Atossa Genetics Acquires Rights to Microcatheter System from Hologic 31
Acquisition 32
Hologic Acquires Cynosure in Tender Offer 32
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 34
Hologic Acquires Beijing Healthcome For Up To US$17 Million 36
Hologic Acquires TCT International 37
Hologic Acquires Interlace Medical 38
Hologic Inc – Key Competitors 40
Hologic Inc – Key Employees 41
Hologic Inc – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Affiliate 44
Recent Developments 45
Financial Announcements 45
Nov 08, 2017: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 45
Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 47
May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 49
Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 50
Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 52
Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016 54
Apr 27, 2016: Hologic Announces Financial Results for Second Quarter of Fiscal 2016 56
Jan 27, 2016: Hologic Announces Financial Results for First Quarter of Fiscal 2016 57
Corporate Communications 59
May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 59
Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 60
Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 61
Mar 02, 2016: Chris Coughlin Elected to Hologic Board of Directors 62
Legal and Regulatory 63
Jan 19, 2016: Hologic’s Tepnel Pharma Services Achieves ISO 17025 Accreditation for Extraction and Genotyping Services 63
Product News 64
Jun 29, 2017: Hologic’s New Panther Fusion System, Flu and Respiratory Assays Now CE Marked in Europe 64
Mar 01, 2017: Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 65
Nov 25, 2016: Hologic to Showcase Award-Winning Breast Screening and Interventional Solutions at RSNA 2016 66
01/06/2016: Metamark Genetics to Serve as Exclusive Sales Agent for Hologic’s Proprietary Prostate Cancer Test 67
Other Significant Developments 68
Aug 09, 2016: HHS awards $4.1 Million to Hologic to Develop better Zika Blood Screening Test 68
Jul 21, 2016: Bovie Medical Announces Sales Channel Partnership Agreement with Hologic for J-Plasma 69
Appendix 70
Methodology 70
About GlobalData 70
Contact Us 70
Disclaimer 70

List of Tables
Hologic Inc, Medical Equipment, Key Facts, 2016 2
Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Hologic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Hologic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Hologic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Hologic Inc, Deals By Market, 2011 to YTD 2017 9
Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 12
Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 13
MeVis Medical Enters into Licensing Agreement with Hologic 14
Microsulis Medical Enters Into Licensing Agreement With Hologic 15
Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 16
Seegene Enters into Agreement with Hologic 17
U.S. Department of Health and Human Services Enters into Agreement with Hologic 18
Bovie Medical Enters into Agreement with Hologic 19
Metamark Genetics Enters into Distribution Agreement with Hologic 20
Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 21
Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 22
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 23
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 24
Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 25
Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 26
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 27
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 29
Atossa Genetics Acquires Rights to Microcatheter System from Hologic 31
Hologic Acquires Cynosure in Tender Offer 32
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 34
Hologic Acquires Beijing Healthcome For Up To US$17 Million 36
Hologic Acquires TCT International 37
Hologic Acquires Interlace Medical 38
Hologic Inc, Key Competitors 40
Hologic Inc, Key Employees 41
Hologic Inc, Other Locations 42
Hologic Inc, Subsidiaries 42
Hologic Inc, Affiliate 44

★海外企業調査レポート[Hologic Inc (HOLX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Foley Family Wines Limited:企業の戦略・SWOT・財務分析
    SummaryFoley Family Wines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Anschutz Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Anschutz Company Mergers and Ac …
  • Oglethorpe Power Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Oglethorpe Power Corporation Me …
  • ProSiebenSat.1 Media AG (PSM):企業の財務・戦略的SWOT分析
    ProSiebenSat.1 Media AG (PSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Compuage Infocom Limited (COMPUAGE):企業概要、財務及び戦略的SWOT分析
    Summary Compuage Infocom Limited (Compuage Infocom) is an information technology distribution company. The company provides information technology products and services. Its products include Fone Pad, ASUS X55C SX026D, Extreme Connect, Bric Connect, Linksys Wi-Fi Router, and Linksys Smart Wi-Fi Rout …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437):企業財務及び戦略的SWOT分析
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a research and development company that produces and markets pharmaceutical drugs. The company’s product portfolio comprises pharmaceutical drugs for treating nutrition disorders, cardiovascular diseases, cancer and musculoskeletal diso …
  • GET Holdings Limited (8100):企業財務及び戦略的SWOT分析
    Summary GET Holdings Limited (GET Holdings), formerly M Dream Inworld Limited is a technology company that develops and distributes antivirus software, personal computer's performance software, and mobile phone applications. The company’s products include iObit, GET Mdream, funshare and e-perfect IT …
  • Alethia Biotherapeutics Inc:企業のM&A・提携動向(医療分野)
    Summary Alethia Biotherapeutics Inc (Alethia Biotherapeutics) is a biotechnology company that discovers and develops therapeutic products. The company’s products include AB-25E9 bone antiresorptive, AB-3A4 invasive carcinomas treatment products, and AB-16B5 EMT inhibitor. It also provides therapeuti …
  • Petromin Resources Ltd. (PTR):企業のM&A・提携動向(石油・ガス分野)
    Summary Petromin Resources Ltd. (Petromin) is a petroleum and natural gas exploration company that produces oil and natural gas. The company owns interest in four oil and gas properties in central Alberta situated along the Western Canada Sedimentary Basin. Its methods are designed to improve reserv …
  • Sungbo Chemical Co., Ltd. (003080):企業の財務及び戦略的SWOT分析
    Summary Sungbo Chemical Co., Ltd. (Sungbo Chemical) is a chemical company that manufactures agricultural chemicals. The company offers pesticides, insecticides, fungicides and herbicides. Sungbo Chemical’s products include hansone GR, ttukttak EC, deulpan SC, akkimi SE, sword EC, sambakja GR, chokil …
  • Celesio AG:企業のM&A・提携・投資分析
    Celesio AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Celesio AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Circle Oil Plc (COP):企業のM&A・提携動向(石油・ガス分野)
    Summary Circle Oil Plc (Circle) is an oil and gas company that explores, develops and produces oil and gas properties. The company produces and supplies gas in Morocco and produces gas and associated liquids in Egypt. It holds permits in the Rharb Basin, Morocco; the Mahdia Permit offshore Tunisia; …
  • Medical & Biological Laboratories Co Ltd (4557)-医療機器分野:企業M&A・提携分析
    Summary Medical & Biological Laboratories Co Ltd (MBL) is a provider of clinical and basic laboratory diagnostics. The company’s products comprise research reagents, diagnostic reagents and companion diagnostics. It provides diagnostic reagents for therapeutic areas of allergy, antiphospholipid synd …
  • Sevan Marine ASA (SEVAN):企業財務及び戦略的SWOT分析
    Summary Sevan Marine ASA (Sevan Marine) is a marine service provider company that specializes in design, engineering and project execution of floating units for offshore applications. The company’s floating production units include piranema spirit, hummingbird spirit, voyageur spirit and seven 1000 …
  • Kinross Gold Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Kinross Gold Corporation Merger …
  • Nipro Corp (8086):企業のM&A・提携動向(医療機器分野)
    Summary Nipro Corp (Nipro) manufactures, develops and sells renal and medical surgical products. The company’s products find application in fields such as cardiology, urology and nephrology, interventional radiology and anesthesiology. Its product portfolio includes renal products, interventional an …
  • Sonoma Pharmaceuticals Inc (SNOA):医療機器:M&Aディール及び事業提携情報
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Eldorado Artesian Springs, Inc.:企業の戦略・SWOT・財務情報
    Eldorado Artesian Springs, Inc. - Strategy, SWOT and Corporate Finance Report Summary Eldorado Artesian Springs, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • OmniComm Systems, Inc. (OMCM):企業のM&A・提携動向(医療機器分野)
    Summary OmniComm Systems, Inc. (OmniComm) is a web-based electronic data capture and eClinical software and services providing company. It provides web-based applications to pharmaceutical, biotech and medical device companies. The company’s solutions allow clinical trial sponsors and investigative …
  • Powerex, Inc.:企業の戦略的SWOT分析
    Powerex, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆